 | Up a level |
McWilliam, SJ, Antoine, DJ, Sabbisetti, V, Turner, MA, Farragher, T, Bonventre, JV, Park, BK, Smyth, RL and Pirmohamed, M
(2012)
Mechanism-based urinary biomarkers to identify the potential for aminoglycoside-induced nephrotoxicity in premature neonates: A proof-of-concept study.
PLoS One, 7.
e43909 - ?.
Oni, L, Hawcutt, DB, Turner, MA, Beresford, MW, McWilliam, S, Barton, C, Park, BK, Murray, P, Wilm, B, Copple, I et al (show 4 more authors)
(2017)
Optimising the use of medicines to reduce acute kidney injury in children and babies.
PHARMACOLOGY & THERAPEUTICS, 174.
55 - 62.
McWilliam, SJ, Antoine, DJ, Rosala-Hallas, A, Jones, A, MacLean, C, Prayle, A, Smyth, AR, Flaherty, L, Shaw, VE, Greenhalf, W et al (show 2 more authors)
(2017)
THE PROTEKT STUDY - A PHASE IIA, RANDOMISED, CONTROLLED, OPEN-LABEL TRIAL OF ROSUVASTATIN FOR THE PREVENTION OF AMINOGLYCOSIDE-INDUCED KIDNEY TOXICITY IN CHILDREN WITH CYSTIC FIBROSIS.
.